Trieu Vuong — Insider Stock Purchases
CHAIRMAN AND CEO. Every open-market stock purchase by Trieu Vuong that we've tracked from SEC Form 4 filings, scored on our six-factor model. Not financial advice.
Tracked buys
1
Total value
$5,175
Most recent
Jun 24, 2026
| Ticker | Insider | Role | Value | Filed | Signal | Score |
|---|---|---|---|---|---|---|
| OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong | CHAIRMAN AND CEO | $5,175 | Jun 24, 2026 | AVOID | 38 |
About this profile
This page collects open-market share purchases disclosed by Trieu Vuong in SEC Form 4 filings. When an insider buys with personal money on the open market, it is the cleanest conviction signal available — far more informative than a sale.
Each purchase is scored with our six-factor methodology. To see how these signals performed against the S&P 500, view the track record, or browse all tracked insiders on the insiders directory.
Not financial advice. For educational purposes only. Form 4 data can be amended or filed late; analysis is generated using AI and may contain errors.
Track new insider buys as they file
One email a day with newly scored CEO insider-buying signals. $3.99/mo, cancel anytime.
Start Free 7-Day Trial